Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A new AI-driven supercycle is unfolding, but you don’t need to chase dramatic bets. This guide explains how agentic A...
In Knoxville, some seniors can retire on Social Security alone, but success hinges on housing status, equity, and dis...
Anthropic's Claude Opus Here: Opus 4.8 brings sharper reasoning and tighter alignment without a price change. This de...
Inflation can quietly erode fixed income’s purchasing power. This practical, straightforward guide shows you how to t...
NAIOP rebrands as CREDA, broadening its mandate to advocate, educate, and connect developers, owners, and investors a...
Markets paused to digest a major memory-chip move while the Nasdaq Composite held steady. This article breaks down wh...
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
A 2024 business sale can push couples into IRMAA tiers in 2026. The two-year lookback means higher Medicare costs for...
If you were starting over in real estate today, what would you do differently? This guide outlines five essential mov...
Investors chasing income with growth potential often look for a reliable pillar. This elite 5.5%-yielding dividend of...
July brings a tech-driven reshuffle in enterprise budgets. IBM warned of softer Q2 demand as clients pivot toward AI ...